Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
about
Lubricin/Proteoglycan 4 binds to and regulates the activity of Toll-Like Receptors In Vitro.Advanced glycated end-products affect HIF-transcriptional activity in renal cellsTendinopathy in diabetes mellitus patients-Epidemiology, pathogenesis, and management.The role of ribosylated-BSA in regulating PC12 cell viability.Sonographic evaluation of the shoulder in asymptomatic elderly subjects with diabetes.Up-regulation of the receptor for advanced glycation end products in the skin biopsy specimens of patients with severe diabetic neuropathy.Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-κB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation.Management of limited joint mobility in diabetic patients.Osteoarthritis of the knee and hip. Part I: aetiology and pathogenesis as a basis for pharmacotherapy.Occurrence of tendon pathologies in metabolic disorders.Genome-wide expression and methylation profiles reveal candidate genes and biological processes underlying synovial inflammatory tissue of patients with osteoarthritis.Alterations of tendons in diabetes mellitus: what are the current findings?Accumulation of advanced-glycation end products (AGEs) accelerates arthrogenic joint contracture in immobilized rat knee.Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells.Studies on the cardioprotective role of gallic acid against AGE-induced cell proliferation and oxidative stress in H9C2 (2-1) cells.Is blood neutrophil-lymphocyte ratio an independent predictor of knee osteoarthritis severity?Effect of glycated albumin and cranberry components on interleukin-6 and matrix metalloproteinase-3 production by human gingival fibroblasts.The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis.Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy.STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers.Intracellular accumulation of advanced glycation end products induces apoptosis via endoplasmic reticulum stress in chondrocytes.Mechanisms of Osteoarthritic Pain. Studies in Humans and Experimental Models.Necrotic cell death caused by exposure to graphitic carbon-coated magnetic nanoparticles.Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation.Obesity, Metabolic Syndrome, and Musculoskeletal Disease: Common Inflammatory Pathways Suggest a Central Role for Loss of Muscle Integrity.Characterization of antioxidant and anti-inflammatory activities of bioactive fractions recovered from a glucose-lysine Maillard reaction model system.HMGB-1 induces IL-6 production in human synovial fibroblasts through c-Src, Akt and NF-κB pathways.Ultrasound morphology of the Achilles in asymptomatic patients with and without diabetes.What is the role of systemic conditions and options for manipulation of bone formation and bone resorption in rotator cuff tendon healing and repair?S100A12 facilitates osteoclast differentiation from human monocytes
P2860
Q27302541-A7831593-C502-4F2D-9919-75A74BCF5198Q28591845-491DDA93-49C4-49A9-99C4-DD6660E8940CQ30238916-69E8711D-7994-4E18-AC39-B60AFDCAAD34Q30416154-A8214E98-6607-4928-A073-E84179928E60Q33765206-B732D8D1-69F4-4134-BD7C-31CEF44AE60DQ34346579-E381061F-A81B-45B0-B2F2-414E22D3DF3DQ35206138-2E525A93-1977-41E0-B8E9-63E21029CBD1Q35530208-FFD369BA-921F-4305-9293-7C4A89517E35Q36851848-0021330E-CBFC-41A4-9212-39A7BDB46697Q37999391-C0181F4F-DF6E-4225-9A6C-836DD40817DEQ38073742-10BE5529-1B44-4E5F-A6B5-42F42F1E72F5Q38460728-A201F44A-F8F1-4617-ABF3-33E44B8F5352Q38461078-3DC53E5C-55D2-4E9B-82BC-1C55CD51DCFFQ38598169-DD92CFAA-7C5A-48DA-9A95-DBE3BAF219CBQ38811614-598C65D4-83F4-4DB6-B36D-62326EA1A9B4Q39347827-A07E9120-69B2-47A3-AC4B-834FCAFF6E73Q40094171-7A92AC22-5D8A-477F-ABCA-CB5DB6D2B269Q40731921-FB4B98E3-E37F-453A-84BA-0FFB5ABA050BQ41226027-17630B66-13BE-4BC5-BCC6-436C4FEF6018Q42756908-08BABF78-46BC-4A3D-91F9-0F707B96C492Q42866173-6F001925-FC5B-40AC-8437-1C373CDBB86BQ43803960-37ADCE8D-D757-42C7-92EC-C3EA5B0A7481Q45792955-AF0B4125-36E3-4E19-BFF9-47F94B3D6264Q50451567-35226B11-EA59-4D9E-8BDB-EE82701CB9EFQ53306751-7D5E1ECF-5762-4D58-9315-31FEE58C83EFQ53703048-FB0E6752-40C2-4809-B0D1-8B40E8496493Q54537146-B6136640-D0B8-4938-999D-405777E40C54Q54594317-5F625BB7-FA1C-42A1-B220-079049742905Q54690847-A49406DF-E9A2-442B-8292-B6EB8FB15703Q57665436-C956A615-746C-4851-B8BC-EFFDD5027204Q58713351-2C7B6B82-F6BF-4274-B176-7504929C8339
P2860
Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advanced glycation end product ...... fibroblast-like synovial cells
@en
Advanced glycation end product ...... ibroblast-like synovial cells.
@nl
type
label
Advanced glycation end product ...... fibroblast-like synovial cells
@en
Advanced glycation end product ...... ibroblast-like synovial cells.
@nl
prefLabel
Advanced glycation end product ...... fibroblast-like synovial cells
@en
Advanced glycation end product ...... ibroblast-like synovial cells.
@nl
P2093
P2860
P356
P1476
Advanced glycation end product ...... fibroblast-like synovial cells
@en
P2093
Christiane Rüster
Gunter Wolf
Gunther Hofmann
Julia Marticke
Manfred Sommer
Sybille Franke
Tzvetanka Bondeva
P2860
P2888
P356
10.1186/AR2807
P577
2009-09-07T00:00:00Z
P5875
P6179
1016562373